BSAC Spring Conference 2021

Stewarding the AMR agenda through the lenses of prevention, diagnosis and treatment
- Held 29-30 April 2021 - REGISTER NOW to access the recorded conference

This conference is CPD accredited and will be available until 27 October 2021.

Dr Philippe Villain Guillot

CEO, Nosopharm

Philippe Villain-Guillot has been Nosopharm’s chief executive officer since co-founding the company in 2009. In this first entrepreneurial venture, he grew the company to include a staff of 8 high-skilled employees and established a robust IP portfolio. Since the inception of the company, Philippe has raised €4.3 million in private equity and €3.4 million in public grants. Prior to co-founding Nosopharm, Philippe gained experience in medicinal chemistry at Evotec (UK) and focused on natural products at CIATEJ (Mexico). Philippe holds a PhD in medicinal chemistry from the University of Montpellier.

Top